GlassScriptPhysician profile
Wolali A Odonkor
NPI 1093824286
$5,202.21
in general payments reported to CMS, 2019-2025
32 companies · $939 in 2025
The $939 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $410 · 2020: $317 · 2021: $777 · 2022: $618 · 2023: $1,040 · 2024: $1,101 · 2025: $939.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,080.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,080.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $909.81 | 2019-2025 | Korlym |
| Lilly USA, LLC | $715.14 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Sanofi-Aventis U.S. LLC | $624.52 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $483.34 | 2020-2025 | Jardiance |
| Novo Nordisk INC | $406.56 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Abbott Laboratories | $324.40 | 2020-2025 | Freestyle Libre 3, Proclaim |
| Xeris Pharmaceuticals, INC. | $263.93 | 2021-2025 | Recorlev, Gvoke Hypopen |
| Dexcom, INC. | $233.42 | 2020-2025 | Dexcom G6 Transmitter |
| Astrazeneca Pharmaceuticals LP | $148.03 | 2019-2022 | |
| Tandem Diabetes Care, INC. | $124.13 | 2021-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Medtronic, INC. | $115.43 | 2021-2023 | Minimed 780g, Intellis Adaptivestim |
| Recordati_rare_diseases_inc. | $96.88 | 2023-2025 | Isturisa, Signifor Lar |
| Cequr Corporation | $87.36 | 2024 | Cequr Simplicity |
| Insulet Corporation | $68.98 | 2021-2025 | Omnipod |
| Madrigal Pharmaceuticals | $61.18 | 2025 | Rezdiffra |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $60.76 | 2023 | Strensiq |
| Beta Bionics, INC. | $51.90 | 2024 | Ilet Bionic Pancreas |
| Antares Pharma, INC. | $49.47 | 2019-2025 | Xyosted |
| Shire North American Group INC | $44.87 | 2019 | |
| Ascendis Pharma Endocrinology INC | $42.39 | 2025 | Yorvipath |
| Takeda Pharmaceuticals U.S.A., INC. | $39.80 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $34.76 | 2022-2023 | |
| Soleno Therapeutics, INC. | $30.35 | 2025 | Vykat Xr |
| Averitas Pharma INC. | $28.16 | 2025 | Qutenza |
| Mannkind Corporation | $27.02 | 2020-2022 | |
| Halozyme INC | $24.92 | 2023 | |
| Ultragenyx Pharmaceutical INC. | $20.81 | 2021 | |
| Chiasma, INC. | $20.77 | 2021 | |
| Amgen INC. | $17.39 | 2024 | Tepezza |
| Ascensia Diabetes Care US INC. | $17.04 | 2023 | |
| Kerecis Limited | $15.23 | 2019 | |
| Pfizer INC. | $13.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wolali Odonkor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.